Stenocare A/S (CPH:STENO)

Denmark flag Denmark · Delayed Price · Currency is DKK
1.085
+0.020 (1.88%)
Apr 28, 2026, 4:48 PM CET
241.19%
Market Cap 46.00M
Revenue (ttm) 7.02M
Net Income (ttm) -2.39M
Shares Out 43.20M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 105,196
Average Volume 170,297
Open 1.065
Previous Close 1.065
Day's Range 1.030 - 1.115
52-Week Range 0.286 - 2.800
Beta 0.48
RSI 51.25
Earnings Date May 7, 2026

About Stenocare

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD, as well as CBD100 oil products. The company was incorporated in 2017 and is based in Randers, Denmark. [Read more]

Sector Healthcare
Founded 2017
Employees 8
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol STENO
Full Company Profile

Financial Performance

In 2025, Stenocare's revenue was 7.02 million, an increase of 214.56% compared to the previous year's 2.23 million. Losses were -2.39 million, -93.07% less than in 2024.

Financial Statements

News

Stenocare Earnings Call Transcript: Q3 2024

Transitioning to a trading company, focusing on high-growth markets and launching the patented Astrum product. Cost reductions, improved equity ratio, and a planned capital raise address recent sales declines and liquidity needs. Permanent legalization in Denmark expected to boost demand.

1 year ago - Transcripts

Stenocare Transcript: Investor Update

Plans include doubling sales and reaching break even in 2024, supported by new product launches and entry into the Canadian market with the innovative Astrum oil. The ongoing TO2 warrant exercise funds expansion, product approvals, and facility upgrades.

2 years ago - Transcripts